Protecting Our Pharmaceutical Supply Chain from China Act of 2020

United States116th CongressS-3635Senate
Updated: May 6, 2020

Summary

Protecting Our Pharmaceutical Supply Chain from China Act of 2020 This bill requires the federal government to maintain a registry of certain foreign-sourced drugs, prohibits federal health care programs from purchasing drugs containing Chinese ingredients, requires drugs to be labeled for country of origin, and offers domestic manufacturing facility tax incentives.

Bill texts

Available versions
Introduced (Senate)View official text

1 version available

All available records shown.

Timeline

Latest companion bill action

HR-6482: Protecting Our Pharmaceutical Supply Chain from China Act of 2020

Referred to the Subcommittee on Oversight and Investigations.

  1. Introduced in Senate

  2. Read twice and referred to the Committee on Finance.

    Senate

All available records shown.